Psoriasis Area and Severity Index (PASI)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
pasi score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Mild0–5
  • Moderate5–10
  • Severe10–20
  • Very Severe20–72
Direct Clinical Answer

The Psoriasis Area and Severity Index (PASI) calculates quantifying total body surface area involvement and staging cutaneous or blistering disease severity. Key inputs include head erythema. Scores guide calculating resuscitation fluid protocols, administering topical or systemic corticosteroids, and wound care. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Quantifies the severity of psoriasis by combining assessment of lesion severity and affected body surface area. This standardized measurement tool evaluates four body regions (head, arms, trunk, legs) with scoring for erythema, induration, and desquamation, providing an objective assessment for clinical practice and research.

Clinical Indication

The Psoriasis Area and Severity Index (PASI) is indicated for bedside clinical practice to support Quantifies the severity of psoriasis by combining assessment of lesion severity and affected body surface area. This standardized measurement tool evaluates four body regions (head, arms, trunk, legs) with scoring for erythema, induration, and desquamation, providing an objective assessment for clinical practice and research.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute thermal burns, extensive bullous eruptions, severe psoriasis, or severe cutaneous adverse reactions. Clinical application is indicated across Dermatology clinics, burn centers, and emergency dermatology triage.

Limitations & Contraindications

Rule of Nines overestimates burn surface area in pediatric anatomy; Lund-Browder charts must be utilized.

Clinical Pearls & Action Plan

Full-body cutaneous examination including all mucous membranes and scalp is necessary to detect early epidermal detachment.

Formula & Variables:

PASI = 0.1 × (E_h + I_h + D_h) × A_h + 0.2 × (E_a + I_a + D_a) × A_a + 0.3 × (E_t + I_t + D_t) × A_t + 0.4 × (E_l + I_l + D_l) × A_l

Input Parameters

NameTypeRequiredDescription
head_erythemaintegerYesErythema (redness) severity in head/neck region(score)
head_indurationintegerYesInduration (thickness) severity in head/neck region(score)
head_desquamationintegerYesDesquamation (scaling) severity in head/neck region(score)
head_areaintegerYesPercentage of head/neck area affected by psoriasis(score)
arms_erythemaintegerYesErythema (redness) severity in upper limbs/arms region(score)
arms_indurationintegerYesInduration (thickness) severity in upper limbs/arms region(score)
arms_desquamationintegerYesDesquamation (scaling) severity in upper limbs/arms region(score)
arms_areaintegerYesPercentage of upper limbs/arms area affected by psoriasis(score)
trunk_erythemaintegerYesErythema (redness) severity in trunk region(score)
trunk_indurationintegerYesInduration (thickness) severity in trunk region(score)
trunk_desquamationintegerYesDesquamation (scaling) severity in trunk region(score)
trunk_areaintegerYesPercentage of trunk area affected by psoriasis(score)
legs_erythemaintegerYesErythema (redness) severity in lower limbs/legs region(score)
legs_indurationintegerYesInduration (thickness) severity in lower limbs/legs region(score)
legs_desquamationintegerYesDesquamation (scaling) severity in lower limbs/legs region(score)
legs_areaintegerYesPercentage of lower limbs/legs area affected by psoriasis(score)

Score Interpretation & Guidance

RangeStageDescription
0–5MildMild psoriasis
5–10ModerateModerate psoriasis
10–20SevereSevere psoriasis
20–72Very SevereVery severe psoriasis

Evidence-Based References (EBM)

  • Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. doi: 10.1159/000250839.DOI: 10.1159/000250839
  • Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol. 2004;51(4):563-9. doi: 10.1016/j.jaad.2004.04.012.DOI: 10.1016/j.jaad.2004.04.012
  • Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210(3):194-9. doi: 10.1159/000083509.DOI: 10.1159/000083509
  • Puzenat E, Bronsard V, Prey S, Gourraud PA, Aractingi S, Bagot M, et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol. 2010;24 Suppl 2:10-6. doi: 10.1111/j.1468-3083.2009.03562.x.DOI: 10.1111/j.1468-3083.2009.03562.x

Related calculators